PXD042025 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Targeting the Post-Synaptic Proteome in Alzheimer Disease with Psychosis |
Description | Individuals with Alzheimer Disease who develop psychotic symptoms (AD+P) experience more rapid cognitive decline and have reduced indices of synaptic integrity relative to those without psychosis (AD-P). We sought to determine whether the postsynaptic density (PSD) proteome is altered in AD+P relative to AD-P, analyzing PSDs from dorsolateral prefrontal cortex of AD+P, AD-P, and a reference group of cognitively normal elderly subjects. The PSD proteome of AD+P showed a global shift towards lower levels of all proteins relative to AD-P, enriched for kinases, proteins regulating Rho GTPases, and other regulators of the actin cytoskeleton. We computationally identified potential novel therapies predicted to reverse the PSD protein signature of AD+P. Five days of administration of one of these drugs, the C-C Motif Chemokine Receptor 5 inhibitor, maraviroc, led to a net reversal of the PSD protein signature in adult mice, nominating it as a novel potential treatment for AD+P. |
HostingRepository | PRIDE |
AnnounceDate | 2023-11-14 |
AnnouncementXML | Submission_2023-11-14_09:01:18.553.xml |
DigitalObjectIdentifier | https://dx.doi.org/10.6019/PXD042025 |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Supported dataset by repository |
PrimarySubmitter | Matthew MacDonald |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | TMT6plex-126 reporter+balance reagent acylated residue; monohydroxylated residue; iodoacetamide derivatized residue |
Instrument | Orbitrap Fusion Lumos |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2023-05-05 09:53:19 | ID requested | |
1 | 2023-06-19 03:47:15 | announced | |
⏵ 2 | 2023-11-14 09:01:27 | announced | 2023-11-14: Updated project metadata. |
Publication List
Krivinko JM, DeChellis-Marks MR, Zeng L, Fan P, Lopez OL, Ding Y, Wang L, Kofler J, MacDonald ML, Sweet RA, Targeting the post-synaptic proteome has therapeutic potential for psychosis in Alzheimer Disease. Commun Biol, 6(1):598(2023) [pubmed] |
10.6019/PXD042025; |
Keyword List
submitter keyword: Human, Brain, Alzheimer Disease with Psychosis |
Contact List
Matthew L MacDonald |
contact affiliation | Univeristy of Pittsbrugh |
contact email | mlmacdonald@gmail.com |
lab head | |
Matthew MacDonald |
contact affiliation | University of Pittsburgh |
contact email | mlmacdonald@gmail.com |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2023/06/PXD042025 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD042025
- Label: PRIDE project
- Name: Targeting the Post-Synaptic Proteome in Alzheimer Disease with Psychosis